Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B

Adefovir (ADV) sequential monotherapy was included in the 2005 Asia-Pacific guidelines for the management of patients with lamivudine (LAM) resistance. However, following the development of ADV resistance, the proportion of resistant variants during combined rescue therapy with ADV and entecavir (ET...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, YANG, LIU, SHUANG, CHEN, YU, ZHENG, SUJUN, ZHOU, LI, LU, FENGMIN, DUAN, ZHONGPING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888018/
https://www.ncbi.nlm.nih.gov/pubmed/27313669
http://dx.doi.org/10.3892/etm.2016.3230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888018/
https://www.ncbi.nlm.nih.gov/pubmed/27313669
http://dx.doi.org/10.3892/etm.2016.3230

Ejemplares similares